MovDisordV3, Main, Merge, bibRecord, 004102

Prospective Comparative Study on Cost-Effectiveness of Subthalamic Stimulation and Best Medical Treatment in Advanced Parkinson's Disease

Identifieur interne : 004102 ( Main/Merge ); précédent : 004101; suivant : 004103

Prospective Comparative Study on Cost-Effectiveness of Subthalamic Stimulation and Best Medical Treatment in Advanced Parkinson's Disease

Auteurs : Francesc Valldeoriola [Espagne] ; Ossama Morsi [Espagne] ; Eduardo Tolosa [Espagne] ; Jordi Rumia [Espagne] ; Maria José Marti [Espagne] ; Pablo Martinez-Martin [Espagne]

Source :

Movement disorders [ 0885-3185 ] ; 2007.

RBID : Pascal:08-0071403

Descripteurs français

Pascal (Inist)
- Pathologie du système nerveux, Maladie de Parkinson, Prospective, Etude comparative, Analyse coût efficacité, Chimiothérapie, Stade avancé, Coût.
Wicri :
- topic : Prospective.

English descriptors

KwdEn :
- Advanced stage, Chemotherapy, Comparative study, Cost efficiency analysis, Costs, Nervous system diseases, Parkinson disease, Prospective.

Abstract

This is an open, prospective, longitudinal study designed to compare two cohorts of patients with advanced Parkinson's disease during 1 year, one undergoing bilateral subthalamic stimulation (STN-DBS) and the other receiving the best medical treatment (BMT), with respect to the clinical effects observed and the medical expenses produced. Assessments were done by using clinical measures and a generic health related quality of life scale. A questionnaire was used to collect direct healthcare resources. As a measure of cost-effectiveness, we calculated life years gained adjusted by health-related quality of life (QALY) and the incremental cost-effectiveness ratio (ICER). Clinical and demographic variables of both groups were comparable at baseline. Total UPDRS scores improved from 50.5 ± 3.6 to 28.5 ± 3.8 in STN-DBS patients and worsened from 44.3 ± 3.3 to 54.2 ± 4 in the control group. Pharmacological costs in the operated patients were 3,799 ± 940∈, while in the BMT group the costs were 13,208 ± 4,966∈. Other medical costs were 1,280 ± 720∈ in the STN-DBS group and 4,017 ± 2,962∈ in BMT patients. Nondirect medical costs were 4,079 ± 1,289 in operated patients and 2,787 ± 1,209∈ in the BMT group. Mean QALYs were 0.7611 ± 0.03 in STN-DBS and 0.5401 ± 0.06 in BMT patients. In STN-DBS patients, the ICER needed to obtain an improvement of one point in the total UPDRS score was of 239.8∈ and the ICER/QALY was of 34,389∈. Cost-effectiveness parameters were mostly related to the degree of clinical improvement and the reduction of pharmacological costs after STN-DBS. An ICER of 34,389∈/QALY is within appropriate limits to consider subthalamic stimulation as an efficient therapy.

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: 001458
to stream PascalFrancis, to step Curation: 001861
to stream PascalFrancis, to step Checkpoint: 001512

Links to Exploration step

Pascal:08-0071403

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Prospective Comparative Study on Cost-Effectiveness of Subthalamic Stimulation and Best Medical Treatment in Advanced Parkinson's Disease</title>
<author><name sortKey="Valldeoriola, Francesc" sort="Valldeoriola, Francesc" uniqKey="Valldeoriola F" first="Francesc" last="Valldeoriola">Francesc Valldeoriola</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Hospital Clinic, Institut de Neurociencies Universitat de Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Morsi, Ossama" sort="Morsi, Ossama" uniqKey="Morsi O" first="Ossama" last="Morsi">Ossama Morsi</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Hospital Clinic, Institut de Neurociencies Universitat de Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Hospital Clinic, Institut de Neurociencies Universitat de Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rumia, Jordi" sort="Rumia, Jordi" uniqKey="Rumia J" first="Jordi" last="Rumia">Jordi Rumia</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Hospital Clinic, Institut de Neurociencies Universitat de Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Marti, Maria Jose" sort="Marti, Maria Jose" uniqKey="Marti M" first="Maria José" last="Marti">Maria José Marti</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Hospital Clinic, Institut de Neurociencies Universitat de Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Martinez Martin, Pablo" sort="Martinez Martin, Pablo" uniqKey="Martinez Martin P" first="Pablo" last="Martinez-Martin">Pablo Martinez-Martin</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Institute of Health Carlos III, National Center for Epidemiology</s1>
<s2>Madrid</s2>
<s3>ESP</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">08-0071403</idno>
<date when="2007">2007</date>
<idno type="stanalyst">PASCAL 08-0071403 INIST</idno>
<idno type="RBID">Pascal:08-0071403</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001458</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001861</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001512</idno>
<idno type="wicri:doubleKey">0885-3185:2007:Valldeoriola F:prospective:comparative:study</idno>
<idno type="wicri:Area/Main/Merge">004102</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Prospective Comparative Study on Cost-Effectiveness of Subthalamic Stimulation and Best Medical Treatment in Advanced Parkinson's Disease</title>
<author><name sortKey="Valldeoriola, Francesc" sort="Valldeoriola, Francesc" uniqKey="Valldeoriola F" first="Francesc" last="Valldeoriola">Francesc Valldeoriola</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Hospital Clinic, Institut de Neurociencies Universitat de Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Morsi, Ossama" sort="Morsi, Ossama" uniqKey="Morsi O" first="Ossama" last="Morsi">Ossama Morsi</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Hospital Clinic, Institut de Neurociencies Universitat de Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Hospital Clinic, Institut de Neurociencies Universitat de Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rumia, Jordi" sort="Rumia, Jordi" uniqKey="Rumia J" first="Jordi" last="Rumia">Jordi Rumia</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Hospital Clinic, Institut de Neurociencies Universitat de Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Marti, Maria Jose" sort="Marti, Maria Jose" uniqKey="Marti M" first="Maria José" last="Marti">Maria José Marti</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Hospital Clinic, Institut de Neurociencies Universitat de Barcelona</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Martinez Martin, Pablo" sort="Martinez Martin, Pablo" uniqKey="Martinez Martin P" first="Pablo" last="Martinez-Martin">Pablo Martinez-Martin</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Institute of Health Carlos III, National Center for Epidemiology</s1>
<s2>Madrid</s2>
<s3>ESP</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2007">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Advanced stage</term>
<term>Chemotherapy</term>
<term>Comparative study</term>
<term>Cost efficiency analysis</term>
<term>Costs</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Prospective</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Pathologie du   système nerveux</term>
<term>Maladie de Parkinson</term>
<term>Prospective</term>
<term>Etude comparative</term>
<term>Analyse coût efficacité</term>
<term>Chimiothérapie</term>
<term>Stade avancé</term>
<term>Coût</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Prospective</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">This is an open, prospective, longitudinal study designed to compare two cohorts of patients with advanced Parkinson's disease during 1 year, one undergoing bilateral subthalamic stimulation (STN-DBS) and the other receiving the best medical treatment (BMT), with respect to the clinical effects observed and the medical expenses produced. Assessments were done by using clinical measures and a generic health related quality of life scale. A questionnaire was used to collect direct healthcare resources. As a measure of cost-effectiveness, we calculated life years gained adjusted by health-related quality of life (QALY) and the incremental cost-effectiveness ratio (ICER). Clinical and demographic variables of both groups were comparable at baseline. Total UPDRS scores improved from 50.5 ± 3.6 to 28.5 ± 3.8 in STN-DBS patients and worsened from 44.3 ± 3.3 to 54.2 ± 4 in the control group. Pharmacological costs in the operated patients were 3,799 ± 940∈, while in the BMT group the costs were 13,208 ± 4,966∈. Other medical costs were 1,280 ± 720∈ in the STN-DBS group and 4,017 ± 2,962∈ in BMT patients. Nondirect medical costs were 4,079 ± 1,289 in operated patients and 2,787 ± 1,209∈ in the BMT group. Mean QALYs were 0.7611 ± 0.03 in STN-DBS and 0.5401 ± 0.06 in BMT patients. In STN-DBS patients, the ICER needed to obtain an improvement of one point in the total UPDRS score was of 239.8∈ and the ICER/QALY was of 34,389∈. Cost-effectiveness parameters were mostly related to the degree of clinical improvement and the reduction of pharmacological costs after STN-DBS. An ICER of 34,389∈/QALY is within appropriate limits to consider subthalamic stimulation as an efficient therapy.</div>
</front>
</TEI>
<affiliations><list><country><li>Espagne</li>
</country>
<region><li>Catalogne</li>
<li>Communauté de Madrid</li>
</region>
<settlement><li>Barcelone</li>
<li>Madrid</li>
</settlement>
</list>
<tree><country name="Espagne"><region name="Catalogne"><name sortKey="Valldeoriola, Francesc" sort="Valldeoriola, Francesc" uniqKey="Valldeoriola F" first="Francesc" last="Valldeoriola">Francesc Valldeoriola</name>
</region>
<name sortKey="Marti, Maria Jose" sort="Marti, Maria Jose" uniqKey="Marti M" first="Maria José" last="Marti">Maria José Marti</name>
<name sortKey="Martinez Martin, Pablo" sort="Martinez Martin, Pablo" uniqKey="Martinez Martin P" first="Pablo" last="Martinez-Martin">Pablo Martinez-Martin</name>
<name sortKey="Morsi, Ossama" sort="Morsi, Ossama" uniqKey="Morsi O" first="Ossama" last="Morsi">Ossama Morsi</name>
<name sortKey="Rumia, Jordi" sort="Rumia, Jordi" uniqKey="Rumia J" first="Jordi" last="Rumia">Jordi Rumia</name>
<name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004102 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 004102 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Merge
   |type=    RBID
   |clé=     Pascal:08-0071403
   |texte=   Prospective Comparative Study on Cost-Effectiveness of Subthalamic Stimulation and Best Medical Treatment in Advanced Parkinson's Disease
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Prospective Comparative Study on Cost-Effectiveness of Subthalamic Stimulation and Best Medical Treatment in Advanced Parkinson's Disease

Prospective Comparative Study on Cost-Effectiveness of Subthalamic Stimulation and Best Medical Treatment in Advanced Parkinson's Disease

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri